These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16279538)
21. [The activity of NK and K cells in people vaccinated and revaccinated against plague]. Pchelintsev SIu; Solokhin EV; Iurov SV; Uraeva VI; Riazantsev SV; Afanas'ev SS; Savel'ev AP; Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):99-102. PubMed ID: 8017139 [TBL] [Abstract][Full Text] [Related]
22. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development]. Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785 [TBL] [Abstract][Full Text] [Related]
23. [Early protection of animals, immunized by a recombinant plague vaccine, from experimental plague]. Gremiakova TA; Amel'chenko VA; Anisimov GA Biull Eksp Biol Med; 1995 Jan; 119(1):54-7. PubMed ID: 7718805 [No Abstract] [Full Text] [Related]
24. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of immunization protection efficacy of plague subunit vaccine]. Zhang QW; Qi ZZ; Xin YQ; Yang YH; Wu HL; Yang HQ; Feng JP; Jin X; Cui BZ; Wang T; Wu BC; Qiu YF; Wang W; Guo ZB; Wang ZY; Yang RF; Wang H; Wang XY Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):785-8. PubMed ID: 20137561 [TBL] [Abstract][Full Text] [Related]
26. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Sanapala S; Rahav H; Patel H; Sun W; Curtiss R Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051 [TBL] [Abstract][Full Text] [Related]
27. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562 [TBL] [Abstract][Full Text] [Related]
28. [The effect of the vaccinal strain of Yersinia pestis on the expression of Fc-gamma receptors on macrophage surfaces]. Vasil'eva GI; Doroshenko EP Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):85-6. PubMed ID: 10356746 [No Abstract] [Full Text] [Related]
30. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague]. Zakrevskiĭ VI; Plekhanova NG Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277 [TBL] [Abstract][Full Text] [Related]
31. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734 [TBL] [Abstract][Full Text] [Related]
32. [A molecular basis of the plague vaccine development]. Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Philipovskiy AV; Smiley ST Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978 [TBL] [Abstract][Full Text] [Related]
34. Newly described cell type may prove valuable in development of plague vaccines against biowarfare. Expert Rev Vaccines; 2011 Mar; 10(3):259. PubMed ID: 21434794 [No Abstract] [Full Text] [Related]
35. [The role of T-suppressors in the formation of plague immunity in mice]. Nazarova LS; Isupov IV; Surikov NN; Piontkovskiĭ SA; Devdariani ZL; Golubeva II; Taranenko TM; Alenkina TV Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):89-93. PubMed ID: 2143614 [TBL] [Abstract][Full Text] [Related]
36. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine. Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064 [TBL] [Abstract][Full Text] [Related]
37. [Infectious-toxic model of plague in mice]. Ryzhko IV; Mishan'kin BN; Tsuraeva RI; Shcherbaniuk AI; Anisimov BI Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):46-50. PubMed ID: 19621819 [TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G; Khan AA; Rao DN Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784 [TBL] [Abstract][Full Text] [Related]
39. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens]. Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769 [No Abstract] [Full Text] [Related]
40. [The activity of NK and K cells in mice vaccinated against plague]. Solokhin EV; Pchelintsev SIu; Iurov SV; Uraeva VI; Afanas'ev SS; Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):42-5. PubMed ID: 7992534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]